Menu visibility control

Video

Events

Startup Surgery

Most Recent

Sponsored

Tech chats: AI’s impact on jobs with EY’s Richard Goold

Investments

Data science firm Exonar raises £1.25m to expand across Europe

FinTech

UK tech unicorn TransferWise expands to Singapore

Press Releases

Mention Me win best tech startup award at Drapers Digital Festival
GamCrowd officially launches the first ever Gambling Tech Week as part of London Tech Week
Redbox Digital Gains Prestigious Magento Global Elite Partner Status

Oxford startup SpyBiotech raises £4m Seed

BioTech
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

SpyBiotech, a startup spun out of Oxford University, has raised £4m in Seed funding from GV (formerly Google Ventures), and Oxford Sciences Innovation (OSI).

The biotech firm has developed a molecular “superglue” designed to tackle diseases and pandemics. The team believes this could be used to create vaccines more quickly than is currently possible.

SpyBiotech will use its new funding to prepare for phase one trials and is initially focusing on virus-like particles (VLPs), which use vaccination to induce immune responses.

Lachlan MacKinnon, principal at OSI, said: “We see the Spy technology as the missing link in rapid and robust VLP vaccine design and see GV as a natural co-investment partner to take this forward.

“We are privileged to be working with four founders who bring such an impressive combination of academic prowess and clinical-stage experience to the company.”

Gregg Bayes-Brown, marketing and communications manager at Oxford University Innovation, suggested he hopes this ends up being the first in a series of investments made by GV into Oxford University companies.

“We rarely ever see a corporate like GV come in at the seed into university companies. If this is the start of a new trend, it could be massive,” he told The Telegraph.

Earlier this month, London-based biotech firm Pulmocide closed a $30.4m Series B round.

The company, which is run by former GlaxoSmithKline scientists, received investment from SV Life Sciences, Johnson & Johnson’s venture capital arm.

Enter your email address to receive updates straight to your inbox

* indicates required
Send me news on...
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Editor's picks

Richard Goold AI jobs

Tech chats: AI’s impact on jobs with EY’s Richard Goold
posted 13 hours ago

Investment

Data science firm Exonar raises £1.25m to expand across Europe
posted 16 hours ago

TransferWise

UK tech unicorn TransferWise expands to Singapore
posted 17 hours ago

Desolenator

CleanTech startup Desolenator wins Duke of York’s Pitch@Palace 7.0
posted on April 26, 2017

investors

UK FinTech firms ‘raised $328m in Q1 2017’
posted on April 26, 2017

acquisition

EdTech startup Gojimo acquired by Telegraph Media Group
posted on April 26, 2017